Outcomes of hepatectomy for hepatocellular carcinoma with bile duct tumour thrombus

Autor: Tiffany C.L. Wong, Chung Mau Lo, See Ching Chan, Sheung Tat Fan, Kenneth S. H. Chok, Wing Chiu Dai, Ronnie T.P. Poon, Albert C. Y. Chan, Tan To Cheung
Rok vydání: 2015
Předmět:
Zdroj: HPB. 17:401-408
ISSN: 1365-182X
DOI: 10.1111/hpb.12368
Popis: This study was presented at the 11th World IHPBA Congress, 22–27 March 2014, Seoul.
BACKGROUND: Hepatocellular carcinoma (HCC) with bile duct tumour thrombus (BDTT) is rare. The aim of the present study was to determine the prognosis of HCC with BDTT after a hepatectomy. METHODS: A retrospective analysis was performed on all HCC patients with BDTT having a hepatectomy from 1989 to 2012. The outcomes in these patients were compared with those in the control patients matched on a 1:6 ratio. RESULTS: Thirty-seven HCC patients with BDTT having a hepatectomy (the BDTT group) were compared with 222 control patients. Patients in the BDTT group had poorer liver function (43.2% had Child-Pugh B disease). More patients in this group had a major hepatectomy (91.9% versus 27.5%, P = 0.001), portal vein resection (10.8% versus 1.4%, P = 0.006), en-bloc resection with adjacent structures (16.2% versus 5.4%, P = 0.041), hepaticojejunostomy (75.7% versus 1.6%, P < 0.001) and complications (51.4% versus 31.1%, P = 0.016). The two groups had similar hospital mortality (2.7% versus 5.0%, P = 0.856), 5-year overall survival (38.5% versus 34.6%, P = 0.59) and 5-year disease-free survival (21.1% versus 20.8%, P = 0.81). Multivariate analysis showed that lymphovascular permeation, tumour size and post-operative complication were significant predictors for worse survival whereas BDTT was not. DISCUSSION: A major hepatectomy, extrahepatic biliary resection and hepaticojejunostomy should be the standard for HCC with BDTT, and long-term survival is possible after radical surgery. © 2014 International Hepato-Pancreato-Biliary Association.
link_to_OA_fulltext
Databáze: OpenAIRE